https://www.has-sante.fr/jcms/p_3461362/fr/roctavian-valoctocogene-roxaparvovec-hemophilie-a 2023 false false false France Valoctocogene Roxaparvovec insurance, health, reimbursement treatment outcome gene therapy factor VIII recombinant fusion proteins guidelines for drug use continuity of patient care Monitoring of liver function (regime/therapy) valoctocogene roxaparvovec infusions, intravenous evaluation of the transparency committee Valoctocogene Roxaparvovec hemophilia A